Navigation Links
Liver cancer marker could yield blood test for early detection
Date:9/18/2007

ATLANTA In the face of an emerging liver cancer crisis in Asia, researchers at the Chinese University of Hong Kong have developed a test that could help millions. Due to widespread hepatitis B virus (HBV) infection, nearly 10 percent of Chinas population is at high risk for hepatocellular carcinoma (HCC), a liver cancer with low survival rates if not detected and treated early. Researchers report on a new blood screening technique that could make it possible to detect early-stage liver cancer and predict how well a patient will do following treatment. They present their data today at the American Association for Cancer Researchs Second International Conference on Molecular Diagnostics in Cancer Therapeutic Development, in Atlanta, Georgia.

According to their report, the Chinese team has detected an altered version of RASSF1A, a tumor suppressing gene, in the blood of HCC patients and in 58 percent of HBV-infected test subjects. Healthy subjects showed no signs of the altered gene. They also found that patients treated for HCC with high blood levels of the gene were more likely to have a relapse of the disease.

A large portion of the population throughout Hong Kong and China are carriers of hepatitis B, so many people are at risk for hepatocellular carcinoma, said K.C. Allen Chan, MBBS a professor at the Chinese University of Hong Kong. And we hope that this will form the basis of an effective clinical test for early detection of hepatocellular carcinoma.

Hepatocellular carcinoma is one of the deadliest forms of cancer in China and throughout Asia, according to the researchers. In the West, liver cancer is usually a secondary cancer, caused by the spread of tumor cells from elsewhere in the body. In China, however, liver cancer mainly manifests as HCC, a primary cancer, which has been linked to hepatitis B and C infection and cirrhosis. Noticeable symptoms do not usually appear until the cancer has progressed, so it is rarely caug
'/>"/>

Contact: Greg Lester
lester@aacr.org
267-646-0554
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Blood Cells Capable of Regenerating Liver
2. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
3. Infant receives first bloodless liver transplant
4. Liver donors can thrive after transplant
5. Antibiotic induces liver damage in children with E.COLI infections.
6. The Effects Of Delaying A Delivery Questioned
7. Baby Lennox Gets Liver Transplant
8. Milk Thistle Not An Effective Cure For Liver Disease
9. Metronidazole Increases Risk Of Premature Deliveries.
10. Early delivery can prevent cancer
11. A new treatment for liver cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...25 years, the number of Americans living with diab...ion in 2009 to 44.1 million in 2034. Over the same...rising from $113 billion to $336 billion, even wit...chers based at the University of Chicago report in...mber of those with diabetes covered by Medicare wi...
(Date:11/26/2009)...ger thrill when on an emotional rollercoaster, stu...y News) -- Call it the fear factor meets the jubil...ctators -- especially those who root for the winni... a closely contested match and victory was in doub..., Chew on that this Thanksgiving weekend as you,...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a...rolina, today announced the expansion of its servi...entist, Dr. Doug Macmillan. , ...ntal is pleased to announce that Dr. Doug Macmilla...mpleted an additional advanced training seminar. ...
(Date:11/25/2009)...INA, Minn., Nov. 25 Whe...their dentist. But a chiropractor can also give p...poral-Mandibular Joint, which is where your jaw (m...al bone). ,, The most common symptoms associat...cking or popping of the jaw. But many other sympt...
(Date:11/25/2009)...ORONTO and CALGARY, Nov. 25 /PRNewswire/ - Sentine...ic Resonance Imaging (MRI) coils and software and ...tware enabling technologies, have introduced a web...tion software. ,, This innovative interface is ...dical imaging offering in the market. Calgary Scie...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...ead regions' in the brain that could be responsibl...by Karolina Kluk, a Cambridge University student. ...opment of individualized hearing aids for children...not be used with babies. The new electrophysiologi...
...nal examination of a child, to determine the locat...gn of abuse. // This was discussed in the American...in Seattle recently. Retina is a light sensiti...e. A wide variety of conditions such as falls...
...ecalled from the market as stated by the FDA due t...cans. // So this brand would not be sold in market...ant formula, Mead Johnson Nutritionals of EVANSVIL...company for the recall is public health concern. A...
...s, preventing the spread of the deadly virus H5N1,...he Eastern past of France. // The farm in Versaill...y turkeys, was just 200mts away from the lake wher...nion farm has got the bird-flu infection. Nearly 8...
... against indiscriminate antibiotic use, saying th...e prescribed inappropriately. //This issue figure...microbials annual scientific discussion meeting in...ncrease in drug-resistant infections. Prof Tur...
...e complication following coronary artery bypass gr...enon gas, a new study has found. // The results o...d in Anesthesiology journal. The researchers...lopment of new treatments for diseases associated ...
Other Medicine News:Health News:New Test Offers Hope in Effective Hearing Aid Design for Babies 2Health News:Retinal Hemorrhage: No More a Sure Sign of Child Abuse 2
(Date:11/25/2009)... The Netherlands and JOHANNESBURG, November 25 /PR...sion and Pyxis Discovery announced today,that they...market both,companies, services. , Pyxis,...covery expertise,will be coupled with iThemba,s se...chemistry support to projects identified through P...
(Date:11/24/2009)...Nov. 24 ,, WHAT: Rom Houbens,... years following an auto accident, was actually fu...he subject of a Good Morning America segment. The...ustrate how people with Locked-in Syndrome and oth...: Good Morning America -- Tuesday, November 24 ...
(Date:11/24/2009)...v. 24 Anadys Pharmaceuti...t will present at the 21st Annual Piper Jaffray He...t 9:00 a.m. EST (6:00 a.m. PST). The conference i...Worland, Ph.D., President and Chief Executive Offi...and its clinical development programs, ANA598 and ...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 1Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 2Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 3Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 4Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 5Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 6Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 7Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 8Eastern Europes First Novalis Tx 28TM 29 Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc 28R 29 Technology 5467 1Eastern Europes First Novalis Tx 28TM 29 Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc 28R 29 Technology 5467 2Eastern Europes First Novalis Tx 28TM 29 Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc 28R 29 Technology 5467 3Baxa Announces IntelliFlowRx 28TM 29 to Become DoseEdge 28TM 29 Dose Management System 5463 1Baxa Announces IntelliFlowRx 28TM 29 to Become DoseEdge 28TM 29 Dose Management System 5463 2
... Pa., Sept. 19 Wyeth,Pharmaceuticals, a division ...Phase 3 fracture data for bazedoxifene, a selectiv...iety for Bone and Mineral Research Annual,Meeting....ene 20 mg and 40,mg significantly reduced the rela... and 37 percent, respectively, compared with place...
...pt. 19 Alba Therapeutics Corporation today,announ...eek Phase IIb trial,with oral AT-1001, an inhibito...maintenance of remission in patients with Celiac D...bo-controlled, dose ranging study will,evaluate th...CD subjects,during a six-week gluten challenge, wh...
Other Medicine Technology:Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis 2Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis 3Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis 4Alba Therapeutics Announces Phase IIb Clinical Trial for Oral AT-1001 for the Treatment of Celiac Disease 2
...ion via the pelvic nerves has proven to be an effe.... Through the use of mild electrical stimulation, ...d to encourage urinary control and continence. Zyn... a tool to aid in the treatment and alleviate the ...
High Dose Rate (HDR) Treatment System
...r Template Set is the HDR solution which duplicate...e. The template set consists of a small grid style...s placed in a Stepper Holder with variable ultraso...ble for different ultrasound stepper devices. The ...
Disposable Template
Medicine Products: